This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Salud financiera de hoja de balance de Concert Pharmaceuticals
Salud financiera controles de criterios 6/6
Información clave
0%
Ratio deuda-patrimonio
US$0
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$149.53m |
| Patrimonio | US$133.27m |
| Total pasivo | US$37.86m |
| Activos totales | US$171.13m |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: 73C's short term assets ($157.2M) exceed its short term liabilities ($17.4M).
Pasivo a largo plazo: 73C's short term assets ($157.2M) exceed its long term liabilities ($20.5M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 73C is debt free.
Reducción de la deuda: 73C had no debt 5 years ago.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: 73C has sufficient cash runway for more than a year based on its current free cash flow.
Pronóstico de cash runway: 73C has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 29.2% each year.